Tuesday, July 1, 2025 7/1/2025

Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption

Award Number: R01CA271500
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/15/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2027

Group Awards By:

View Award Description

Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption - PROJECT SUMMARY (DESCRIPTION) Circadian rhythms coordinate behavior and physiology with predictable daily environmental cycles. The timing of circadian cycles is primarily determined by the timing of light exposure. Chronic disruption of circadian rhythms, such as that experienced during shift work or travel across time zones, increases the risk of several types of cancer in people. A handful of studies has shown that exposure to altered light cycles designed to recapitulate so-called “chronic jet lag” experienced by shift workers enhances tumorigenesis in genetically engineered mouse models of breast, liver, and lung cancers. We have established that exposure to a lighting schedule that mimics chronic jet lag increases tumor formation in a mouse model of KRAS-driven lung adenocarcinoma. Furthermore, we found that tumors from mice exposed to chronic circadian disruption express higher levels of genes that are activated by the heat stress response factor, HSF1. HSF1 has been shown to facilitate tumorigenesis in several systems, and may be particularly pathogenic in RAS-driven cancers. We hypothesize that chronic circadian disruption causes elevated activity of HSF1, thus leading to aggravated oncogenic activity of KRASG12D, and increased tumorigenesis. This proposal will examine whether HSF1 is required for increased formation of KRASG12D-driven lung tumors in response to circadian disruption. In Aim 1 of this project, we will use genetic deletion of Hsf1 either throughout the animal or exclusively within tumors to investigate its role in increased tumorigenesis caused by circadian disruption in KrasLSLG12D mice (a.k.a. Krastm4TyJ). In Aim 2 of this project, we will use a combination of bulk RNA sequencing, digital cytometry, detection of differential rhythmicity, and location-barcoded sequencing of tumor-bearing lung sections to reveal additional molecular mechanisms that could contribute to enhanced tumorigenesis in response to environmental disruption of circadian rhythms.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $606,729 )
2025	2025	SCRIPPS RESEARCH INSTITUTE	10550 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Biology Research	001	3	6/2/2025	NON-COMPETING CONTINUATION	$60,673
2025	2025	SCRIPPS RESEARCH INSTITUTE	10550 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Biology Research	000	3	11/13/2024	NON-COMPETING CONTINUATION	$546,056
														Subtotal = $606,729

Issue Date FY: 2024 ( Subtotal = $556,033 )
2024	2024	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Biology Research	000	2	11/14/2023	NON-COMPETING CONTINUATION	$537,153
2024	2024	SCRIPPS RESEARCH INSTITUTE	10550 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Biology Research	001	2	4/16/2024	NON-COMPETING CONTINUATION	$18,880
														Subtotal = $556,033

Issue Date FY: 2023 ( Subtotal = $640,055 )
2023	2023	SCRIPPS RESEARCH INSTITUTE, THE	10550 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Biology Research	000	1	12/15/2022	NEW	$640,055
														Subtotal = $640,055

Grand Total All Awards = $1,802,817

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption

Award Number: R01CA271500

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/15/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer